News from the American Medical Association (AMA) House of Delegates

Sarah Sprinkle, MHPTT, CT(ASCP)CM, Vice Chair of The ASC Bulletin and CytoPathPod Editorial Board, interviews Drs. Margaret Compton, Current Delegate for the ASC to the AMA House of Delegates; Swati Mehrotra, Past delegate and current alternate delegate for the ASC to the AMA House of Delegates; and Mark Synovec, Chair of the Pathology Section Council.

The insightful panel discussed the various roles and impact of the American Medical Association (AMA), with a focus on its House of Delegates component and the importance of representation for different societies and individuals. They also addressed current issues such as a proposed rule by the FDA on laboratory-developed tests, the impact of HPV-associated cancer prevention, and the need for fair reimbursement for digital pathology services. Lastly, they emphasized the importance of younger physicians getting involved in their State Medical Societies as well as participating in national advocacy efforts. The AMA plays a significant role as the voice of medicine in Washington on a broad spectrum of issues ranging from regulatory matters to reimbursement through the RUC and CPT advisory processes, so it is critical for cytopathology to have representation.

Apply to the AMA Today! https://member.ama-assn.org/join-renew/member-search [member.ama-assn.org].  And https://www.ama-assn.org/amaone/ama-general-group-membership [ama-assn.org]

One important thing that we want to highlight is that in order to maintain HOD representation, we need a certain percentage of physician ASC members to also be AMA members. There are also opportunities for resident and fellow members to participate in the resident and fellows section. 

Click here for Dr. Margaret Compton's informative article Updates from the 2023 AMA House of Delegates Interim Meeting in the January issue of The ASC Bulletin.